Ì첩ÌåÓý

Joshua J Gagne, PharmD, ScD is an Associate Professor of Medicine at Brigham and Women’s Hospital and Harvard Medical School and an Associate Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health (Harvard Chan). Josh is Co-Lead of the Methods Core of the US Food and Drug Administration’s (FDA’s) Sentinel program, Co-Director of the Pharmacoepidemiology Program at Harvard Chan, and Co-Director of the Harvard-Brigham Drug Safety and Risk Management Research Center funded by the FDA.

His research centers on methods for generating post-approval comparative safety and effectiveness evidence for new medical products. Josh teaches courses in pharmacoepidemiology and comparative effectiveness research at Harvard Chan and directs a course through Harvard Catalyst, the Harvard Clinical and Translational Science Center. His research is supported by the FDA, the Patient-Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality, the Reagan-Udall Foundation, and pharmaceutical companies.

Josh is a recipient of the International Society for Pharmacoeconomics and Outcomes Research Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research. He serves on the editorial boards of Drug Safety and Pharmacoepidemiology and Drug Safety and is an Associate Editor for PCORI.